General Information of the Compound
Compound ID |
CP0088334
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one
Show/Hide
|
||||||||||||||||||
Synonyms |
1,9-Pyrazoloanthrone
129-56-6
1TW30Y2766
2,6-DIHYDROANTHRA/1,9-CD/PYRAZOL-6-ONE
2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
2H-Dibenzo[cd,g]indazol-6-one
ACPOUJIDANTYHO-UHFFFAOYSA-N
ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE
Anthra-1,9-pyrazol-6-none
Anthra[1,9-cd]pyrazol-6(2H)-one
BRN 0746890
CHEBI:90695
CHEMBL7064
CI 70300
Dibenzo[cd,g]indazol-6(2H)-one
EINECS 204-955-6
JNK Inhibitor II
MLS002693964
NSC 75890
Pyrazolanthrone
Pyrazoleanthrone
SAPK Inhibitor II
SP 600125
SP-600125
SP600125
UNII-1TW30Y2766
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H8N2O
|
||||||||||||||||||
Molecular Weight |
220.231
|
||||||||||||||||||
Canonical SMILES |
O=C1c2ccccc2-c2n[nH]c3cccc1c23
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)
Show/Hide
|
||||||||||||||||||
InChIKey |
ACPOUJIDANTYHO-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
129-56-6
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00998, Mitogen-activated protein kinase 10
Protein ID: PT00863, Mitogen-activated protein kinase 8
Protein ID: PT00872, Mitogen-activated protein kinase 9
Clinical Information about the Compound
Drug 1 ( 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One )
Drug Name | 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One | ||
---|---|---|---|
Target(s) |